Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

CVRx, Inc.

CVRX · Nasdaq · CIK 0001235912 · Healthcare · Medical Devices

INSIDER SIGNAL

44.3 / 100

1 buyers · 1 purchase transaction lines · $76.3K gross purchase

WHY THIS SIGNAL?

Buyer breadthLow
Purchase sizeLow
RoleStrong
RecencyLow
ConvictionStrong
Score anatomy

Each bar shows the contribution to the current score; the weights and formula stay unchanged.

Cluster+7.0 / 35
Purchase size+6.4 / 25
Role+18.0 / 20
Recency+3.3 / 10
Conviction+9.6 / 10

What is holding the score back?

  • ⚠ Cluster breadth is moderate · 1 insider(s), not 4+
  • ⚠ Purchase size is modest relative to the model scale
  • ⚠ Purchase activity is becoming less recent
  • ✓ Role scores high · most senior buyer: CHIEF OPERATING OFFICER

Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.

US-v1.2 ranks qualifying equity purchases under the current 180-day rules. The score is a research priority, not a return forecast or probability. Backtests have not shown that a higher US score is followed by better returns.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Binkowski BrentCHIEF OPERATING OFFICER
▼●
Nielsen Kirk G.Director
○
Jain Mudit K.Director
○
SLATTERY JOSEPH PDirector
○
Hill, Mitch C.Director
○
Ballinger Kevin J.Director
○
● Purchase▼ Sale○ Other

Showing the six most active owners; 2 additional owner(s) remain in Form 4 evidence.

Purchase breadth & concentration

QUALIFYING BUYERS1
PURCHASE CONCENTRATION100%Largest buyer: Binkowski Brent · $76.3K
CLUSTER BUYING · 15D1 insiderPeak activity: 2026-08-13–2026-08-13

Roles in the peak window: CHIEF OPERATING OFFICER. Concentration uses priced qualifying P lines only and does not change the saved score.

SIGNAL HISTORY

44.3 / 100

Latest recorded score

↓ -0.1 ptsversus the previous recorded snapshot
  1. 44.8
  2. 44.6
  3. 44.5
  4. 44.4
  5. 44.3

Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.

Recent Form 4 activity

3Purchases
14Sales
14Other Form 4 lines
23SEC filings · 365 days
BUYING1 qualifying P line(s) · 180 days
SELLING1 sale line(s) · context only
OTHER7 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.

Price performance

1M
-44.8%
3M
-70.9%
6M
-77.9%
12M
-82.7%

Volatility & liquidity

Volatility
102.7%
Beta
—
Avg daily value
USD 1.5M

Valuation

Market cap
USD 42.1M
P/E
—

Fundamentals

Profit margin
-94.1%
ROE
-135.6%
Industry
Medical Devices

Market data

Price data up to: 2026-10-11 · Price source: OpenBB/yfinance; volume from price cache (yfinance) · From SEC filings: Market cap, Profit margin, ROE · Fiscal year ended: 2025-12-31 · Market cap is the shares outstanding stated on the filing cover multiplied by the latest close. Share count date: 2026-07-30 · Status: PASS

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
1,982,426
Previous report
1,643,732
Avg daily volume
826,036
Days to cover
2.4

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-13Binkowski BrentPurchase (P)Common Stock26,223USD 2.91USD 76,309SEC filing ↗
2026-02-20Jain Mudit K.Purchase (P)Common Stock46,800USD 6.36USD 297,648SEC filing ↗
2026-02-18Jain Mudit K.Purchase (P)Common Stock600USD 4.64USD 2,784SEC filing ↗
2025-05-15Nielsen Kirk G.Purchase (P)Common Stock10,966USD 5.45USD 59,765SEC filing ↗
2025-05-14Nielsen Kirk G.Purchase (P)Common Stock61,200USD 5.23USD 320,076SEC filing ↗
2025-05-13Nielsen Kirk G.Purchase (P)Common Stock101,413USD 5.29USD 536,475SEC filing ↗
2025-05-13Jain Mudit K.Purchase (P)Common Stock150USD 5.26USD 789SEC filing ↗
2025-05-12Nielsen Kirk G.Purchase (P)Common Stock25,200USD 4.79USD 120,708SEC filing ↗
2025-05-12Jain Mudit K.Purchase (P)Common Stock1,500USD 4.66USD 6,990SEC filing ↗
2025-05-12Hykes KevinPurchase (P)Common Stock5,000USD 4.84USD 24,200SEC filing ↗
2024-08-15SLATTERY JOSEPH PPurchase (P)Common Stock3,000USD 8.10USD 24,300SEC filing ↗
2024-08-08SLATTERY JOSEPH PPurchase (P)Common Stock3,000USD 8.24USD 24,720SEC filing ↗
2024-08-06SLATTERY JOSEPH PPurchase (P)Common Stock2,500USD 9.09USD 22,725SEC filing ↗
2024-08-05Hykes KevinPurchase (P)Common Stock30,000USD 8.36USD 250,800SEC filing ↗
2022-05-24Nielsen Kirk G.Purchase (P)Common Stock8,070USD 5.05USD 40,754SEC filing ↗

Form 4 evidence

31 transaction lines in the latest 365-day window; 193 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-13Binkowski BrentPurchase (P)Common Stock26,223USD 2.91USD 76,309SEC filing ↗
2026-08-12Binkowski BrentSale (S)Common Stock1,309USD 2.55USD 3,338SEC filing ↗
2026-06-01SLATTERY JOSEPH PAward / grant (A)Common Stock8,720USD 0.00USD 0SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-13Binkowski BrentPurchase (P)Common Stock26,223USD 2.91USD 76,309SEC filing ↗
2026-08-12Binkowski BrentSale (S)Common Stock1,309USD 2.55USD 3,338SEC filing ↗
2026-06-01SLATTERY JOSEPH PAward / grant (A)Common Stock8,720USD 0.00USD 0SEC filing ↗
2026-06-01SHADAN MARTHAAward / grant (A)Common Stock8,720USD 0.00USD 0SEC filing ↗
2026-06-01Nielsen Kirk G.Award / grant (A)Common Stock8,720USD 0.00USD 0SEC filing ↗
2026-06-01Jain Mudit K.Award / grant (A)Common Stock8,720USD 0.00USD 0SEC filing ↗
2026-06-01Hill, Mitch C.Award / grant (A)Common Stock8,720USD 0.00USD 0SEC filing ↗
2026-06-01DALE MICHAEL DAward / grant (A)Common Stock29,005USD 0.00USD 0SEC filing ↗
2026-06-01Ballinger Kevin J.Award / grant (A)Common Stock8,720USD 0.00USD 0SEC filing ↗
2026-03-02Adamson Philip B.Sale (S)Common Stock1,262USD 7.90USD 9,970SEC filing ↗
2026-03-02Morrison GregoryAward / grant (A)Common Stock34,000USD 0.00USD 0SEC filing ↗
2026-03-02VERRASTRO PAULSale (S)Common Stock1,284USD 7.90USD 10,144SEC filing ↗
2026-03-02OASHEIM JAREDSale (S)Common Stock1,744USD 7.90USD 13,778SEC filing ↗
2026-03-02John Robert AllenSale (S)Common Stock3,964USD 7.90USD 31,316SEC filing ↗
2026-03-02Hykes KevinSale (S)Common Stock7,763USD 7.90USD 61,328SEC filing ↗
2026-02-27Adamson Philip B.Award / grant (A)Common Stock41,000USD 0.00USD 0SEC filing ↗
2026-02-27VERRASTRO PAULAward / grant (A)Common Stock45,000USD 0.00USD 0SEC filing ↗
2026-02-27OASHEIM JAREDAward / grant (A)Common Stock61,000USD 0.00USD 0SEC filing ↗
2026-02-27John Robert AllenAward / grant (A)Common Stock35,000USD 0.00USD 0SEC filing ↗
2026-02-27Hykes KevinAward / grant (A)Common Stock159,000USD 0.00USD 0SEC filing ↗
2026-02-27Binkowski BrentAward / grant (A)Common Stock15,000USD 0.00USD 0SEC filing ↗
2026-02-20Jain Mudit K.Purchase (P)Common Stock46,800USD 6.36USD 297,648SEC filing ↗
2026-02-18Jain Mudit K.Purchase (P)Common Stock600USD 4.64USD 2,784SEC filing ↗
2025-11-26JOHNSON & JOHNSON; Johnson & Johnson Innovation - JJDC, Inc.Sale (S)Common Stock6,337USD 10.03USD 63,560SEC filing ↗
2025-11-26JOHNSON & JOHNSON; Johnson & Johnson Innovation - JJDC, Inc.Sale (S)Common Stock6,337USD 10.03USD 63,560SEC filing ↗
2025-11-25JOHNSON & JOHNSON; Johnson & Johnson Innovation - JJDC, Inc.Sale (S)Common Stock16,000USD 10.03USD 160,480SEC filing ↗
2025-11-24JOHNSON & JOHNSON; Johnson & Johnson Innovation - JJDC, Inc.Sale (S)Common Stock2,200USD 10.06USD 22,132SEC filing ↗
2025-11-21JOHNSON & JOHNSON; Johnson & Johnson Innovation - JJDC, Inc.Sale (S)Common Stock500USD 10.00USD 5,000SEC filing ↗
2025-11-12JOHNSON & JOHNSON; Johnson & Johnson Innovation - JJDC, Inc.Sale (S)Common Stock1,000USD 10.00USD 10,000SEC filing ↗
2025-11-07JOHNSON & JOHNSON; Johnson & Johnson Innovation - JJDC, Inc.Sale (S)Common Stock200USD 10.00USD 2,000SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerCVRX
CIK0001235912
SectorHealthcare
IndustryMedical Devices Yahoo Finance
SEC SIC3841 Surgical & Medical Instruments & Apparatus
ExchangeNasdaq

Data coverage

Local Form 4 history193 transaction lines from 2021-06-30 to 2026-08-13
41 P purchase lines · 21 S sale lines · 131 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.